Another indicator that the PIK3CA mutations we identified drive the development of HSA is that 7 of the 9 cases bearing PIK3CA mutations have fewer than 10 additional mutations (apart from those found in PIK3CA and TP53), and these are not obvious cancer drivers. Here, ALB is linked to cancer.